R&D Services offer
Seqens offers complete and fully integrated R&D services to support your project from initial stage to commercial manufacturing in total compliance with the highest quality, safety and environmental standards.
complete and fully integrated R&D services
Seqens has a balanced portfolio of Big Pharma, mid-sized, specialty pharmaceutical and emerging pharmaceutical companies in the United States, Europe and Japan. We have the flexibility to scale up or down to meet the needs of any customer, whether:
- An emerging pharmaceutical company that wants to develop a small molecule
- A mid-sized company looking for a reliable partner to commercialize a Phase I or Phase II molecule and bring it to market or sell it to a Big Pharma company
- A large pharmaceutical company that needs a partner with multi-site manufacturing capacity for all aspects of API development through Phase I, Phase II and Phase III, and the organizational capability for strong project management to ensure coordinated timelines and protocols and consistent quality
Seqens gives you the best of both worlds—a small, dedicated team, along with the support of a large corporation. The key to your success is our commitment to deliver best-in-class quality-by-design (QbD) methodologies, analytical evaluation, characterization and regulatory services.
Strong R&D capabilities to develop distinctive, cutom-made solutions, to speed up ours clients’ projects by adding value :
- 3 state-of-the-art R&D center in Europe and the US
- Our unique range of technologies enables us to manufacture complex molecules for small- and large-scale demands
EXPLORE OUR
R&D services RANGE
DISCOVER PORCHEVILLE 360°TOUR
DISCOVER SEQENS R&D SERVICES OFFER
Our locations
Boston'Lab (Devens)
United StatesMA 01434Devens
Facility Highlights:
- 10,000 sq. ft. facility with 6 laboratories that house 28 hoods.
- 30 person staff, ¾ PhD’s
- 5 kilo lab hoods
Equipment:
- Glassware from ml to 100 liter jacketed glass vessels
- 20 and 50 liter rotovaps
- Various filtration equipment
- Temperature ranges -78 – 240°C
- Thin film evaporation
- Flash chromatography
- Prep chromatography
- Micronization
- High pressure par reactors
Porcheville (Seqens'Lab)
France78440 Porcheville
Surface: 40, 000 m²
Lab surface: 2, 000 m²
Capabilities:
- 6 kilo-labs
- 2 cGMP pilot plants with 11 multipurpose reactors from 100 L to 2, 800 L (total capacity of 12 m³)
- Temperature range: -15/+150°C (hastelloy reactor: -80/+200°C)
- 3 finishing rooms (agitated filter dryers, filters, dryers, milling and sieving equipments)
Flagship technologies:
- Crystallization expertise and technologiesd(salt, co-crystal and polymorph screenings, process development)
- Process Safety expertise and tecnologies
- Flow chemistry for fine chemicals
- Potent API process development
- Genotoxic Impurities
- Issue Management
- Generic A.P.I Solid state expertise
Last inspection: ANSM October 2018
Certification: GMP
Number of scientists: 110
Other: Ecosystem Pharma with integrated services
Nîmes Protéus by Seqens
France30000 Nîmes
Surface: 1, 000 m²
Lab surface: 500 m²
Capacities:
- 1 kilo-lab in fermentation (80 L total capacity)
- Robotic platform for highthroughput screening (HTS)
- Analytical platform for chromatography (GC, GC-MS, U-HPLC)
Flagship technologies:
- Protein engineering
- Microbiology aerobic & anaerobic
- Syngas fermentation
- Enzymes & strains fermentation
- Biochemistry
- Biocatalysis
- Design of experiments (DoE)
- Data mining
Number of scientists: 19
EcoVadis CSR Rating: Silver Certification
